Omega-6 and omega-3 fatty acids: Partners in prevention

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 2, 2010, Pages 125-129

  Harris, William ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Coronary heart disease; Diet; Fish oil; Nutrition; Vegetable oil

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; EPADEL; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID ETHYL ESTER; LINOLEIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ACUTE HEART INFARCTION; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY RISK; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; METABOLIC SYNDROME X; NONHUMAN; NUT; PREVENTIVE MEDICINE; REVIEW; RISK REDUCTION; STROKE; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

CARDIOVASCULAR DISEASES; DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; LINOLEIC ACID; MALE;

EID: 76749125875     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283357242     Document Type: Review

References (42)

1. Sears B. The omega Rx zone: the miracle of the new high-dose fish oil. New York NY: HarperCollins; 2003.
2. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002; 56:365-379.
3. Hamazaki T, Okuyama H. The Japan Society for Lipid Nutrition recommends to reduce the intake of linoleic acid. A review and critique of the scientific evidence. World Rev Nutr Diet 2003; 92:109-132.
4. Yokoyama M,Origasa H,Matsuzaki M, etal. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007; 369:1090-1098.
5. Oikawa S, Yokoyama M, Origasa H, et al. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucosemetabolism: sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2009; 206:535-539.
6. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subana-lysis of the JELIS trial. Stroke 2008; 39:2052-2058.
7. Saito Y, Yokoyama M, Origasa H, et al. Effects of EPA on coronary arterydisease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008; 200:135-140.
8. Matsuzaki M, Yokoyama M, Saito Y, et al. Incremental effects of eicosapen-taenoic acid on cardiovascular events in statin-treated patients with coronaryartery disease. Circ J 2009; 73:1283-1290.
9. Iso H, Kobayashi M, Ishihara J, etal. Intake offish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006; 113:195-202.
10. Sekikawa A, Curb JD, Ueshima H, et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008; 52:417-424.
11. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009; 139:804S-819S.
12. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008; 10:503-509.
13. Lavie CJ, Milani RV, Mehra MR, et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009; 54:585-594.
14. Kris-Etherton PM, Innis S. Position of the American Dietetic Association and Dieticians of Canada: Dietary Fatty Acids. J Am Diet Assoc 2007; 107:1599-1611.
15. Harris WS. International recommendations for consumption of long-chain omega-3 fatty acids. J Cardiovasc Med (Hagerstown) 2007; 8 (Suppl 1): S50-S52.
16. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885-1899.
17. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006; 84:5-17.
18. Harris WS, Miller M, Tighe AP, et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197:12-24.
19. Block RC, Harris WS, Reid KJ, et al. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2007; 197:821-828.
20. SiscovickDS, RaghunathanTE, King I, etal. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc 1995; 274:1363-1367.
21. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007; 193:1-10.
22. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346:1113-1118.
23. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 2004; 39:212-220.
24. Stahl LA, Begg DP, Weisinger RS, et al. The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 2008; 9:57-64.
25. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006; 63:1545-1550.
26. Barberger-Gateau P, Raffaitin C, Letenneur L, etal. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007; 69:1921-1930.
27. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008; 126:826-833.
28. Clarke R, Shipley M, Armitage J, et al. Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants. Br J Nutr 2008; 102:279-284.
29. Shearer GC, Pottala JV, Spertus JA, et al. Red blood cell fatty acid patterns and acute coronary syndrome. PLoS ONE 2009; 4:e5444.
30. Wilson PW, D'Agostino RB, Levy D, etal. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 18:1837-1847.
31. Block RC, Harris WS, Reid KJ, et al. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 2008; 156:1117-1123.
32. Harris WS, Mozaffarian D, Rimm EB, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Committee. Circulation 2009; 119:902-907.
33. Gordon DJ. Lowering cholesterol and total mortality. In: Rifkin BM, editor.Lowering cholesterol in high-risk individuals and populations. New York: Marcel Dekker; 1995. pp. 33-48.
34. Jakobsen MU, O'Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009; 89:1425-1432.
35. Liou YA, King DJ, ZibrikD, etal. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007; 137:945-952.
36. Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 2009; 50 (Suppl):S52-S56.
37. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous antiinflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005; 73:141-162.
38. Buchanan MR, Horsewood P, Brister SJ. Regulation of endothelial cell and platelet receptor-ligand binding by the 12-and 15-lipoxygenase monohydr-oxides, 12-, 15-HETE and 13-HODE. Prostaglandins Leukot Essent Fatty Acids 1998; 58:339-346.
39. Kalyanaraman B. Nitrated lipids: a class of cell-signaling molecules. Proc Natl Acad Sci USA 2004; 101:11527-11528.
40. Fritsche KL. Too much linoleic acid promotes inflammation-doesn't it? Prostaglandins Leukot Essent Fatty Acids 2008; 79:173-175
41. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino Acids. 2002. Washington, DC: National Academies Press. p. 6.
42. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2005; v4. NHLBI. doi: 02-5215.